Kythera Biopharmaceuticals Inc. (KYTH) is a clinical-stage biopharmaceutical company engaged in the discovery, development and commercialization of prescription products for the aesthetic medicine market. KYTH is trading at $56.80 close the upper end of its 52 week range of $29.86-$57.50. Year to date the stock has outperformed the market rallying a whopping 64.1%. The stock continued to rip to the upside in today’s session by about 6.76% or $3.59.
Early in the session a trader bought 1,000 of the KYTH July 65.0 Calls for $0.69 when the stock was trading at $53.90. This order was recorded about fifteen minutes after the open on OptionHacker, and the stock rose about $3.54 to $57.44 after the trade hit the tape. Over 1,500 contracts have been traded today hinting at bullish sentiment. The KYTH July 65.0 Calls have traded as high as $2.70 in today’s session making this a highly profitable trade. This stock gapped up overnight and has continued to trade above the Ichimoku Cloud on intraday time frames from today’s session. The stock is most likely bullish today because the FDA is scheduled to discuss the company’s drug for treatment of double chin.
Trade: A trader bought 1,000 of the KYTH July 65.0 Calls for $0.69
Risk: $69 per 1 lot
If a trader bought a 20 lot of these Calls they would have profited $4,020 at the highs on $1,380 in risk. This is a great example of a hugely profitable UOA trade.